Provided by Tiger Trade Technology Pte. Ltd.

Artivion

39.59
+0.13000.33%
Post-market: 39.590.00000.00%17:52 EST
Volume:291.04K
Turnover:11.53M
Market Cap:1.88B
PE:-172.13
High:40.17
Open:40.00
Low:39.35
Close:39.46
52wk High:48.25
52wk Low:21.97
Shares:47.37M
Float Shares:41.69M
Volume Ratio:0.69
T/O Rate:0.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2300
EPS(LYR):-0.3200
ROE:-2.46%
ROA:1.95%
PB:4.28
PE(LYR):-123.73

Loading ...

Earning Preview: Artivion Q4 revenue is expected to increase by 15.47%, and institutional views are cautiously positive

Earnings Agent
·
Feb 05

Lake Street Sticks to Their Buy Rating for Artivion (AORT)

TIPRANKS
·
Yesterday

Artivion Price Target Maintained With a $58.00/Share by Needham

Dow Jones
·
Feb 03

Artivion: Positive Clinical Data and Pipeline Progress Support Sustained Growth and Buy Rating

TIPRANKS
·
Feb 03

Artivion (AORT) Receives a Buy from Lake Street

TIPRANKS
·
Feb 02

Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Artivion (AORT)

TIPRANKS
·
Feb 02

Artivion announces presentations of clinical data from Nexus and AMD trials

TIPRANKS
·
Feb 02

Artivion Reports Strong Survival and Low Morbidity in NEXUS TRIOMPHE and AMDS PERSEVERE Trials

Reuters
·
Feb 02

Artivion Inc - Nexus Triomphe Trial Shows High Patient Survival and Low Morbidity

THOMSON REUTERS
·
Feb 02

Artivion Announces Presentation of Positive New Clinical Data From Nexus Triomphe and Amds Persevere Trials at the 62Nd Society of Thoracic Surgery Annual Meeting

THOMSON REUTERS
·
Feb 02

Artivion Inc. to Release Fourth Quarter Financial Results and Host Earnings Call

Reuters
·
Jan 30

Artivion Chief Commercial Officer John E. Davis Reports Sale of Common Shares

Reuters
·
Dec 18, 2025

Does Artivion’s 2025 Surge Still Make Sense After Recent Medtech Rally?

Simply Wall St.
·
Dec 15, 2025

Evaluating Artivion (AORT) After a Strong Multi‑Year Rally: Is the Stock Still Undervalued?

Simply Wall St.
·
Dec 09, 2025

Artivion SVP and General Counsel Jean F. Holloway Sells Common Shares

Reuters
·
Dec 05, 2025

Artivion CEO James P. Mackin Reports Disposal of Common Shares

Reuters
·
Dec 04, 2025

A Look at Artivion’s (AORT) Valuation Following Strong Q3 Results and Raised Full-Year Guidance

Simply Wall St.
·
Nov 25, 2025

Artivion SVP Marshall S. Stanton Reports Disposal of Common Shares

Reuters
·
Nov 25, 2025

Artivion Director Makes Significant Stock Sale!

TIPRANKS
·
Nov 20, 2025

Artivion Director Elizabeth A. Hoff Reports Sale of Common Shares

Reuters
·
Nov 20, 2025